Zoom Logo

Thromboprophylaxis of Hospitalized COVID-19 Patients - Shared screen with speaker view
Lisa Rask
14:56
Lisa Rask--Willapa Harbor Hospital
Kathy Collins
14:58
`Kathy Collins
Kimberly Lueders
14:59
Kim Lueders Providence Medical Center Wayne, NE
Dawn Bolzman
15:04
Dawn Bolzman, Hills and Dales General Hospital
Heather Bergeron
15:07
Heather Bergeron, RiverView Health
Amy Combs
15:18
Amy Combs Cherokee Nation WW Hastings Hospital in Tahlequah, OK
Carla Harvey
15:25
Carla Harvey, Jefferson County Health Center
Lee Williamson
15:26
Lee Williamson, Stephens Memorial Breckenridge, Tx
Sharon Hendricks
15:44
Sharon Hendricks, ACNP-BC Prowers Medical Center
Tammy Clements
16:14
Tammy Clements Hereford Regional Medical Center
Telligen HQIC
16:41
Welcome Everyone!
Sharmin Rice
18:51
Shar Rice Memorial Regional Health Craig, CO
Meg Nugent
41:11
Please enter any questions you may have in the chat.
Deborah Ann Lansdowne
43:38
Are the slides available for download?
Meg Nugent
46:52
Hi Deborah. The slides and recording will be sent out to all participants once the recording is available.
Deborah Ann Lansdowne
47:19
Thank you!
Brenda Quiring
49:37
What are your thoughts for a more therapeutic approach for those with elevated BMI's as this group has a higher incidence of mortality?
Brenda Quiring
49:42
Can these slides be shared?
Christine LaRocca
50:16
for patients with a fib and other conditions who are on chronic Direct Oral Anticoagulants (DOACs)-- apixaban, rivaroxaban (Xarelto) and others) and are admitted with COVID-19--- is there any added value of low molecular weight heparin?
Meg Nugent
51:09
Once the recording is available, we will share the slide deck and recording.
Danyce Seney
55:01
I have a situation I have to attend to, I would very much like to have a copy of the recording. Fabulous!!!!
Christine LaRocca
59:33
I noted that aspirin was one of the agents in the CORE-19 study in patients post-discharge. Was aspirin effective and if so, at what dose? I ask because aspirin is inexpensive and may be easier to administer than LMWH in older adults
Christine LaRocca
59:51
I noted that aspirin was one of the agents in the CORE-19 study in patients post-discharge. Was aspirin effective and if so, at what dose? I ask because aspirin is inexpensive and may be easier to administer than LMWH in older adults
Brenda Quiring
01:09:27
Any recommendation on pregnant patients with their increase inflammatory responses?
Lynda Martin
01:11:39
Thanks so much for this excellent presentation and discussion during Chat!
Christine LaRocca
01:12:02
thank you, Dr. Spyropoulos!!!
Lynn Van Vactor
01:12:12
Excellent presentation thank you!!
Lynda Martin
01:12:42
Excellent presentation - very interesting!
Janelle Shearer
01:13:01
Thank you - this was fantastic!